Blood Donation by Patients With Hemochromatosis-Reply
Alfred J. Grindon
Abstract
Alfred J. Grindon
Abstract
In Reply. —As Dr Friedrich states, patients with hemochromatosis are quite capable of providing units of blood. However, the number of such patients in the United States is so few that they would provide only a minimal increase in available blood. I differ with him in his feeling that patients with hemochromatosis do not gain from blood donation. These patients currently incur significant cost and inconvenience in obtaining therapeutic phlebotomy services from hospitals, physicians' offices, or blood centers, and therefore may seek to be blood donors to avoid these costs, whether qualified or not. Finally, it is generally believed by regulating and accrediting agencies that laboratory procedures alone are insufficient to provide the required minimal risk of transfusion-transmitted disease. Dr Penning notes correctly that donor motivation is insufficient for product safety; however, it is a necessary element. As he points out, the practice of using this blood is allowed if
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In Reply. —As Dr Friedrich states, patients with hemochromatosis are quite capable of providing units of blood. However, the number of such patients in the United States is so few that they would provide only a minimal increase in available blood. I differ with him in his feeling that patients with hemochromatosis do not gain from blood donation. These patients currently incur significant cost and inconvenience in obtaining therapeutic phlebotomy services from hospitals, physicians' offices, or blood centers, and therefore may seek to be blood donors to avoid these costs, whether qualified or not. Finally, it is generally believed by regulating and accrediting agencies that laboratory procedures alone are insufficient to provide the required minimal risk of transfusion-transmitted disease. Dr Penning notes correctly that donor motivation is insufficient for product safety; however, it is a necessary element. As he points out, the practice of using this blood is allowed if
Key concepts: Phlebotomy, Medicine, Blood donor, Hemochromatosis, Donation, Feeling, Intensive care medicine, Blood transfusion